Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,110.00
Bid: 1,109.00
Ask: 1,113.00
Change: 18.00 (1.65%)
Spread: 4.00 (0.361%)
Open: 1,094.00
High: 1,117.00
Low: 1,080.00
Prev. Close: 1,092.00
BUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2020 Portfolio Progress & Full Year Results 2019

28 Apr 2020 07:00

RNS Number : 1232L
Burford Capital Limited
28 April 2020
 

This announcement contains inside information

 

28 April 2020

 

 

BURFORD CAPITAL REPORTS 2020 PORTFOLIO PROGRESS, STRONG 2019 GROWTH AND ROBUST CASH GENERATION

 

Burford Capital Limited ("Burford Capital" or "Burford" or "the Company"), the leading global finance and asset management firm focused on law, today announces an update on its 2020 portfolio progress and its financial results for the year ended 31 December 2019, which are consistent with the guidance provided in our 3 February 2020 trading update. Burford's complete annual report and audited accounts, which are significantly expanded this year, are available at http://www.rns-pdf.londonstockexchange.com/rns/1232L_1-2020-4-28.pdf or the Burford website: www.burfordcapital.com.

 

2020 Portfolio progress

 

On 3 February 2020, Burford reported that it had achieved litigation successes that would trigger unrealized gains and, if ultimately affirmed and paid, would generate more than $150 million in Group-wide income and more than $100 million in balance sheet income.

 

Since then, Burford has enjoyed further substantial successes in its portfolio. In the first four months of 2020 Burford has obtained court results or arbitral awards that, if paid in full, would generate substantial income and cash receipts:

 

· Almost $800 million in Group-wide cash receipts and more than $450 million in balance sheet cash receipts

 

· More than $500 million in Group-wide income and approximately $300 million in balance sheet income, against which less than $1.5 million had been realised through 31 December 2019 in balance sheet fair value gains

 

· As a subset of the foregoing, more than $300 million in balance sheet cash receipts and $200 million in balance sheet income either in the form of arbitral awards or appellate court judgments from which further legal review is unlikely ("Final Matters"), and if not paid promptly will result in the creation of substantial unrealised gain or receivables while payment is awaited

 

The expected cash receipts should provide a meaningful addition to Burford's already healthy cash liquidity to reinvest in new matters.

 

The balance sheet numbers above do not include future balance sheet entitlement to performance fees on what would be more than $200 million in fund income, $150 million of which in Final Matters.

 

It is noteworthy that, in just the first four months of 2020, Burford has seen several significant case successes that if ultimately affirmed and paid would generate meaningful profits and cash receipts. This is in keeping with our commentary in our annual report (at pages 54-55) about the unpredictability of the timing of outcomes but the ultimate delivery of performance.

 

Risk remains in litigation until matters actually pay cash, and it is always possible that the anticipated income described above will be reduced by further court action, prepayment discounts or by agreement between the parties.

 

2019 Financial highlights1

 

· Sustained client demand for Burford's capital saw 29% growth in core litigation finance and asset recovery new commitments to $955 million (2018: $739 million)

o Total commitments reached a new all-time high of $1.6 billion, up 19%

o Deployments exceeded $1 billion for the third year in a row

o Burford's portfolio grew to $4.2 billion (2018: $3.2 billion)

 

· Burford generated more than $1 billion in cash in 2019, with $518 million on Burford's balance sheet (2018: $526 million)

o Balance sheet cash receipts were more than 4x operating expenses and finance costs, leaving $397 million available for distribution or deployment into new legal finance assets

 

· Return on invested capital in balance sheet core litigation finance portfolio rose from 85% to 93% for an IRR of 31%

 

· Quiet second half for asset realisations drove lower Burford-only adjusted operating profit of $279 million (2018: $355 million) and lower profit after tax of $226 million (2018: $329 million); operating margin of 78%

 

· Total Burford-only income was down 15% at $357 million (2018: $420 million)

o As indicated in our 3 February 2020 trading update, net realised gains were $28 million lower than in 2018 (trading update range: $20-30 million lower) and net unrealised gains were $52 million lower than in 2018 (trading update range: $50-70 million lower)

o Unrealised gains as a share of total income decreased to 52% (2018: 57%) 

 

· Over $200 million in balance sheet cash and cash management assets at year end 2019, plus $185 million in capital provision indirect assets with relatively short average lives, providing ample liquidity to manage COVID-19 environment

 

· Burford's private funds saw total assets under management rise to $2.9 billion (2018: $2.5 billion), generating $26 million of income, up 65%, on AUM growth and $7.1 million of income from our sovereign wealth fund arrangement

 

[1] Figures for total income, operating profit, profit before tax and profit after tax in this release exclude the impact of amortisation of the intangible asset, operating expenses incurred related to (i) one-time expenses related to equity and listing matters and (ii) case-related legal fees not included in asset cost, and third-party interests in consolidated entities, and are shown to assist understanding of the underlying performance of the Company.

 

Sir Peter Middleton, Chairman of Burford, commented:

 

"2019 was a year of contrasts, marked by the continued expansion of our business yet also by the disruption of a meritless short attack. Though our business fundamentals remained strong, investor confidence was dented, causing shareholders to urge changes to our governance. We responded by restructuring our Board, including nominating new directors, appointing a new CFO and reorganising our senior management, and announcing a plan to seek a dual share listing in the US. In addition, we have continued to increase and improve the transparency of our disclosure. I believe Burford will emerge stronger than ever, with a significantly increased capability to sustain its leadership of the global legal finance industry into the firm's second decade."

 

Christopher Bogart, Chief Executive Officer of Burford, added:

 

"Against the measure of success of growing Burford's business and generating substantial free cash, Burford had a spectacular year, and 2020 is off to a terrific start. We are the market leader in a rapidly growing industry with high and uncorrelated returns, and we expect meaningful demand for our services in light of the current economic disruption. We have significant cash on hand in addition to our proven cash generating capacity and access to hundreds of millions of dollars of fund capital to boot. And much as we share the world's distress at our current health crisis, the reality is that we expect its aftermath to be a time of significant demand for our services and a moment when uncorrelated cash flows are especially attractive."

 

COVID-19

 

Burford has provided at page 73 of its annual report an extensive discussion about the risks and opportunities to its business from the current COVID-19 pandemic and what we expect to be an ensuing economic downturn. In short, while the pandemic could well result in delays in the realisation of Burford's assets, those delays are timing rather than substantive and the risks to Burford's business are considerably less than many other companies, while also creating the likelihood of business opportunities going forward.

 

Financial Summary

 

A financial summary of Burford's results is set out below. As usual, this summary is presented without third-party interests in Burford's consolidated entities and after certain adjustments to assist in understanding the underlying performance of the Company.

 

 

 

 

2019

 

2018

% change

 

 

$'000

 

$'000

 

 

 

 

 

 

 

Capital provision income

 

316,780

 

392,525

 

Asset management income

 

26,130

 

15,799

 

Services and other income

 

13,800

 

12,050

 

 

 

 

 

 

 

Total income*

 

356,710

 

420,374

-15%

 

 

 

 

 

 

Operating expenses

 

(77,412)

 

(65,494)

 

 

 

 

 

 

 

Operating profit*

 

279,298

 

354,880

-21%

 

 

 

 

 

 

Finance costs

 

(39,622)

 

(38,538)

 

 

 

 

 

 

 

Profit before tax*

 

239,676

 

316,342

-24%

 

 

 

 

 

 

Taxation

 

(13,417)

 

12,463

 

 

 

 

 

 

 

Profit after tax*

 

226,259

 

328,805

-31%

 

 

 

 

 

 

* Total income, operating profit, profit before tax and profit after tax exclude the impact of amortisation of the intangible asset, operating expenses incurred related to (i) one-time expenses related to equity and listing matters and (ii) case-related legal fees not included in asset cost, and third-party interests in consolidated entities.

Investor and Analyst Conference Call

 

Burford will host a conference call for investors and analysts at 2.00pm (British Summer Time) / 9.00am (Eastern Daylight Time) on Tuesday 28 April 2020.

 

Burford encourages investors and analysts to pre-register for dedicated audio webcast access via:

https://www.investis-live.com/burfordcapital/5e6113f2fe2c790a007aaf4e/kgfd.

 

The dial-in number for the conference call is +44 (0)20 3936 2999 / +1 646 664 1960 and the access code is 916118.

 

An accompanying presentation will be available on the Burford Capital website: http://www.burfordcapital.com/investors.

 

A replay facility will be available until Tuesday 12 May 2020 by dialling +44 (0)20 3936 3001 / +1 845 709 8569 with the replay code 047970.

 

Share issuance for LTIP awards

 

In connection with the delivery of vested LTIP awards to employees the Company has allotted and issued 400,000 new Ordinary Shares of nil par value each in the capital of the Company (the "New Shares"). Application has been made to the London Stock Exchange plc for admission to trading of the New Shares on AIM ("Admission"). The Admission is expected to take place at 8.00am (British Summer Time) on 29 April 2020.

 

Following admission of the New Shares the Company will have 219,049,877 Ordinary Shares of nil par value each in issue. There are no shares held in treasury. Therefore, following admission of the New Shares the total number of voting rights in the Company will be 219,049,877 (the "Voting Rights Figure"), and this Voting Rights Figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their voting rights interest, or a change to that interest, in the Company.

 

Corporate calendar

 

Burford will hold its AGM on 13 May 2020.

 

Given (i) the delay in the release of Burford's FY 2019 results due to COVID-19; (ii) the continuing backlog of audit work; and (iii) the process associated with Burford's US listing , Burford anticipates releasing its interim results for the period ended 30 June 2020 later than usual, and perhaps as late as the latter part of September 2020. If Burford releases its interim results prior to obtaining a US listing, that would cause further delay in the listing process as the interim results will need to be incorporated into a revised registration statement.

 

 

For further information, please contact:

 

Burford Capital Limited

 

Jim Kilman, Chief Financial Officer

+1 917 985 9840

Robert Bailhache, Head of Investor Relations - email

 

+44 (0)20 3530 2023

Macquarie Capital (Europe) Limited - NOMAD and Joint Broker

+44 (0)20 3037 2000

Jonny Allison

 

Alex Reynolds

 

 

 

Jefferies International Limited - Joint Broker

+44 (0)20 7029 8000

Graham Davidson

 

Tony White

 

 

 

Numis Securities Limited - Joint Broker

+44 (0)20 7260 1000

Charlie Farquhar

 

Jonathan Abbott

 

 

 

 

About Burford Capital

Burford Capital is the leading global finance and asset management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the London Stock Exchange, and it works with law firms and clients around the world from its principal offices in New York, London, Chicago, Washington, Singapore and Sydney.

 

For more information about Burford: www.burfordcapital.com

 

 

This release does not constitute an offer of any Burford fund. Burford Capital Investment Management LLC ("BCIM"), which acts as the fund manager of all Burford funds, is registered as an investment adviser with the U.S. Securities and Exchange Commission. The information provided herein is for informational purposes only. Past performance is not indicative of future results. The information contained herein is not, and should not be construed as, an offer to sell or the solicitation of an offer to buy any securities (including, without limitation, interests or shares in the funds). Any such offer or solicitation may be made only by means of a final confidential Private Placement Memorandum and other offering documents.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FR DZGZDDRLGGZG
Date   Source Headline
29th Jun 202311:14 amRNSIntended Purchases of Ordinary Shares
26th Jun 20236:00 pmRNSDirector/PDMR Shareholding
26th Jun 20232:08 pmRNSUpdate & Release Date for 2Q23 Results
26th Jun 20232:07 pmRNSNotice of Early Redemption of Bonds due 2024
26th Jun 20232:05 pmRNSClosing of Private Offering of Senior Notes
23rd Jun 20237:00 amRNSPricing of Senior Notes Offering
22nd Jun 20235:22 pmRNSDirector/PDMR Shareholding
20th Jun 20231:00 pmRNSPrivate Offering of Senior Notes
13th Jun 202312:00 pmRNS1Q23 Results & Quarterly Report
8th Jun 20233:00 pmRNSNotice of 1Q23 Results & Results Call Details
6th Jun 202312:00 pmRNSNotice of Retail Shareholder Call on June 21, 2023
6th Jun 202312:00 pmRNSNotice of 2023 AGM
2nd Jun 202312:00 pmRNSSterling FX Rate for Second 2022 Interim Dividend
16th May 202312:00 pmRNSAvailability of 2022 Annual Report
16th May 202312:00 pmRNSAnnual results for year ended December 31, 2022
3rd May 20237:00 amRNSNotice of 2022 Results and Update on Accounting
3rd Apr 20237:30 amRNSRestoration - Burford Capital Limited
3rd Apr 20237:00 amRNSStatement on YPF Summary Judgment Ruling
31st Mar 20234:57 pmRNSSuspension - Burford Capital Limited
31st Mar 20234:14 pmRNSStatement re Petersen and Eton Park Matters
29th Mar 20233:00 pmRNSTransaction in Own Shares
22nd Mar 20234:00 pmRNSDirector/PDMR Shareholding
16th Mar 20237:00 amRNSUpdate on 2022 Business Activity
3rd Jan 202312:00 pmRNSUpdate on and Completion of Share Purchases by EBT
30th Dec 20221:13 pmRNSDirector/PDMR Shareholding
28th Dec 202212:00 pmRNSUpdate on Share Purchases by EBT
16th Dec 202212:00 pmRNSUpdate on Share Purchases by EBT
9th Dec 20225:00 pmRNSDirector/PDMR Shareholding
9th Dec 20227:00 amRNSIntended Share Purchases by Employee Benefit Trust
25th Nov 202212:00 pmRNSDirector/PDMR Bondholding
16th Nov 202212:00 pmRNSAppointment of Joint Corporate Broker
9th Nov 202212:00 pmRNSSterling FX Rate for 2022 Interim Dividend
1st Nov 20221:23 pmRNSBurford Capital Releases 2022 GC Survey Results
13th Sep 20223:27 pmRNSBurford Capital-Report on Class Action Recoveries
6th Sep 20227:00 amRNSJordan Licht Appointed Chief Financial Officer
26th Aug 20222:00 pmRNSDirector/PDMR Shareholding
24th Aug 20222:00 pmRNSDirector/PDMR Shareholding
16th Aug 20222:00 pmRNSPDMR Shareholding and Transaction in Own Shares
9th Aug 202212:01 pmRNSDr. Rukia Baruti Appointed as Board Director
9th Aug 202212:00 pmRNSInterim Results for six months ended 30 June 2022
26th Jul 20222:00 pmRNSTR-1: Notification of Major Holdings
26th Jul 202212:00 pmRNSNotice of 1H22 Results Date & Results Call Details
25th Jul 20222:00 pmRNSTR-1: Notification of Major Holdings
27th Jun 202211:30 amRNSDirector/PDMR Shareholding
15th Jun 20225:30 pmRNSPurchases of Shares for NED Plan and PDMR Notices
13th Jun 20227:00 amRNS$350 Million Post-Settlement Investment Fund Close
10th Jun 20223:00 pmRNSIntended Purchases of Ordinary Shares
7th Jun 20223:00 pmRNSNotification of Major Holdings
1st Jun 20223:00 pmRNSRetail Shareholder Call Registration Details
1st Jun 202210:00 amRNSSterling FX Rate for 2021 Final Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.